Product Image

N.O.-Xplode Fruit Punch

4.7
★ ★ ★ ★ ★
(934 ratings)
Sodium 110 mg
Potassium 200 mg
Product Image
Score51
Disclosed minerals cannot offset a main performance blend with no assessable doses. The lack of stimulant transparency is especially limiting for cardiovascular suitability.
How scoring works
Powder
Quantity:2 lb(s) • (60 servings)
Goals:

Score 51

Disclosed minerals cannot offset a main performance blend with no assessable doses. The lack of stimulant transparency is especially limiting for cardiovascular suitability.
How scoring works
$65.49($1.09 per serving)
Vitacost
$ 68.99
iHerb
$ 65.49
Report prices

Analysis

The powder lists 125 mg of magnesium, 200 mg of potassium, and several vitamins. These amounts add some micronutrient value but do not establish a focused cardiovascular or electrolyte formula.

The N.O.-Xplode Master Performance Blend has no usable dose or component detail in the supplied data. Its main performance effects and any stimulant exposure therefore cannot be evaluated.

The formula is best considered an opaque pre-workout rather than a heart-health supplement. People with hypertension or rhythm concerns do not have enough label information to make a well-informed choice about the principal blend.

Who is it for
  • Pre-workout users comfortable with proprietary blends
  • Adults seeking a flavored exercise powder
Best for
  • General pre-workout use
  • Users who do not require full active disclosure

Pros

  • Lists magnesium and potassium amounts
  • Includes several B vitamins
  • Contains only 5 g of carbohydrate

Cons

  • Main blend doses are hidden
  • Mineral forms are not identified
  • Poor fit for targeted heart support

Warnings

  • People with hypertension or rhythm concerns cannot assess possible stimulant exposure from the undisclosed performance blend.

Nutrient quality

55 Moderate impact

The sodium source is not identified, so its form quality cannot be assessed confidently. The 110 mg sodium amount is too low for substantial sweat replacement.

.

Ingredient transparency

42 Lower impact

A blend or combined matrix prevents full active-dose assessment. The undisclosed blend and missing excipient details materially limit transparency.

.

Customer satisfaction

62 Moderate impact

The supplied average rating is generally strong and the rating volume provides an aggregate signal. No comment-level evidence is provided to assess recurring complaints or confirm how experience matches the intended purpose.

.

Value for money

49 Lower impact

The low sodium contribution or weak disclosure limits effective value. Hidden or secondary ingredients reduce confidence in core value.

.
Report analysis

Ingredients

IngredientAmount per serving
Calories
20 Calorie(s)
Total Carbohydrate
5 Gram(s)
Vitamin D
12.5 mcg
Thiamine
2 mg
Niacin
20 mg
Vitamin B6
2 mg
Folate
330 mcg DFE
Vitamin B12
6 mcg
Pantothenic Acid
10 mg
Calcium
40 mg
Magnesium
125 mg
Sodium
110 mg
Potassium
200 mg
N.O.-Xplode Master Performance Blend
0 NP
Adults 18–50 Women
Report overview
Sodium · 110 mg OverallScore56
D- Active Ingredient Quality & BioavailabilityC- Dose, Safety & Label TransparencyB+ Value

The 110 mg sodium serving is too low for substantial athletic sweat replacement. The label gives a sodium amount without identifying its source. Magnesium and potassium are listed without their chemical forms. Cost per serving is near the collection benchmark.

Potassium · 200 mg OverallScore32
F Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyF Value

The disclosed potassium amount provides moderate support but falls below the collection median. The chemical form is not identified, so its absorption and buffering qualities cannot be assessed. The serving cost is not compelling for the modest potassium contribution.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies.
    D'Elia L; Barba G; Cappuccio FP; Strazzullo P · Journal of the American College of Cardiology · 2011
    Meta-analysis247,510 participants11 studies pooledHeart Health forPotassium
  2. Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials.
    Poorolajal J; Zeraati F; Soltanian AR; Sheikh V; Hooshmand E; Maleki A · PloS one · 2017
    Meta-analysis1,213 participants23 studies pooledHeart Health forPotassium
  3. Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies.
    D'Elia L; Cappuccio FP; Masulli M; La Fata E; Rendina D; Galletti F · Nutrients · 2023
    Meta-analysis332 participants5 studies pooledHeart Health forPotassium
  4. Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length.
    Behers BJ; Behers BM; Stephenson-Moe CA; Vargas IA; Meng Z; Thompson AJ; Melchor J; Wojtas CN; Rosario MA; Baker JF; Deevers AC; Mouratidis RW; Sweeney MJ · Nutrients · 2024
    Meta-analysisHeart Health forPotassium
  5. Potassium intake and risk of stroke in women with hypertension and nonhypertension in the Women's Health Initiative.
    Seth A; Mossavar-Rahmani Y; Kamensky V; Silver B; Lakshminarayan K; Prentice R; Van Horn L; Wassertheil-Smoller S · Stroke · 2015
    Cohort study90,137 participantsHeart Health forPotassium
  6. Effect of high potassium diet on endothelial function.
    Blanch N; Clifton PM; Petersen KS; Willoughby SR; Keogh JB · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2015
    Randomized trial35 participantsHeart Health forPotassium
  7. Associations between sodium, potassium, and blood pressure: results from the Hispanic Community Health Study/Study of Latinos, a prospective cohort study.
    Swift SL; Sotres-Alvarez D; Raij L; Wassertheil-Smoller S; Schneiderman N; Llabre M; Zeki Al Hazzouri A; Rundek T; Van Horn L; Daviglus M; Castaneda S; Youngblood M; Mossavar-Rahmani Y; Elfassy T · The American journal of clinical nutrition · 2024
    Cohort study11,429 participantsHeart Health forPotassium
  8. Serum potassium levels provide prognostic information in symptomatic heart failure beyond traditional clinical variables.
    Toledo CC; Vellosa Schwartzmann P; Miguel Silva L; da Silva Ferreira G; Bianchini Cardoso F; Citelli Ribeiro V; Paim LR; Antunes-Correa LM; Carvalho Sposito A; Matos Souza JR; Modolo R; Nadruz W; Fernandes de Carvalho LS; Coelho-Filho OR · ESC heart failure · 2021
    Cohort study178 participantsHeart Health forPotassium
  9. Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality.
    Núñez J; Bayés-Genís A; Zannad F; Rossignol P; Núñez E; Bodí V; Miñana G; Santas E; Chorro FJ; Mollar A; Carratalá A; Navarro J; Górriz JL; Lupón J; Husser O; Metra M; Sanchis J · Circulation · 2019
    Cohort study2,164 participantsHeart Health forPotassium
  10. Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.
    Vardeny O; Vaduganathan M; Claggett BL; Desai AS; Jhund PS; Lam CSP; Senni M; Shah SJ; Voors AA; Zannad F; Pitt B; Matsumoto S; Merkely B; Zieroth S; Yilmaz MB; Lay-Flurrie J; Viswanathan P; Horvat-Broecker A; Scalise A; McMurray JJV; Solomon SD · JAMA cardiology · 2025
    Randomized trial6,001 participantsHeart Health forPotassium